{"title":"Frasier syndrome presenting with persistent Pseudomonas aeruginosa bacteremia during intensive immunosuppressive therapy: a case report.","authors":"Mizuki Odagi, Tomohiko Yamamura, Yuka Kimura, Shuhei Aoyama, Yuta Inoki, Hideaki Kitakado, Chika Ueda, Yu Tanaka, Tomoko Horinouchi, China Nagano, Shingo Ishimori, Norishige Yoshikawa, Kandai Nozu","doi":"10.1007/s13730-026-01209-z","DOIUrl":null,"url":null,"abstract":"<p><p>Childhood-onset steroid-resistant nephrotic syndrome (SRNS) is caused by monogenic abnormalities in approximately 30% of cases, and is generally unresponsive to immunosuppressive therapy. However, in routine clinical practice, additional immunosuppression is often initiated before the results of genetic testing become available, thereby potentially increasing the risk of severe infection. We report the case of a 3-year-old girl with SRNS in which kidney biopsy showed focal segmental glomerulosclerosis, and there was persistent heavy proteinuria despite methylprednisolone pulse therapy and oral cyclosporin. During the clinical course, she developed persistent Pseudomonas aeruginosa bacteremia, and contrast-enhanced computed tomography suggested portal vein thrombosis as the infectious focus. Genetic testing subsequently identified a WT1 variant (NM_024426.6: c.1447 + 4C > T), establishing the diagnosis of Frasier syndrome. After immunosuppressive therapy was discontinued, in conjunction with ongoing antimicrobial and supportive treatment, she became afebrile and blood cultures became negative. This case highlights not only the importance of early genetic testing in SRNS to avoid ineffective immunosuppressive therapy, but also the potential for intensive immunosuppression to precipitate life-threatening infection, even in pediatric patients.</p>","PeriodicalId":9697,"journal":{"name":"CEN Case Reports","volume":"15 6","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CEN Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13730-026-01209-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Childhood-onset steroid-resistant nephrotic syndrome (SRNS) is caused by monogenic abnormalities in approximately 30% of cases, and is generally unresponsive to immunosuppressive therapy. However, in routine clinical practice, additional immunosuppression is often initiated before the results of genetic testing become available, thereby potentially increasing the risk of severe infection. We report the case of a 3-year-old girl with SRNS in which kidney biopsy showed focal segmental glomerulosclerosis, and there was persistent heavy proteinuria despite methylprednisolone pulse therapy and oral cyclosporin. During the clinical course, she developed persistent Pseudomonas aeruginosa bacteremia, and contrast-enhanced computed tomography suggested portal vein thrombosis as the infectious focus. Genetic testing subsequently identified a WT1 variant (NM_024426.6: c.1447 + 4C > T), establishing the diagnosis of Frasier syndrome. After immunosuppressive therapy was discontinued, in conjunction with ongoing antimicrobial and supportive treatment, she became afebrile and blood cultures became negative. This case highlights not only the importance of early genetic testing in SRNS to avoid ineffective immunosuppressive therapy, but also the potential for intensive immunosuppression to precipitate life-threatening infection, even in pediatric patients.
期刊介绍:
Clinical and Experimental Nephrology (CEN) Case Reports is a peer-reviewed online-only journal, officially published biannually by the Japanese Society of Nephrology (JSN). The journal publishes original case reports in nephrology and related areas. The purpose of CEN Case Reports is to provide clinicians and researchers with a forum in which to disseminate their personal experience to a wide readership and to review interesting cases encountered by colleagues all over the world, from whom contributions are welcomed.